Isotopes for Hope: Canada’s 2030 Promise

For nearly a century, Canada has been at the forefront of medical isotope development, bringing new hope to patients around the world. By harnessing the strength of our nuclear sector, world-class research, and exceptional healthcare expertise, Canada remains a global leader in the fight against cancer. Looking ahead, the country has a remarkable opportunity to double isotope production by 2030 through cross-sector collaboration—building on a proud legacy to shape a brighter future for patients. Join us to explore how Canada is advancing innovation, collaboration, and patient care in this critical field.

Speakers:

Leslie McWilliams, President and CEO, Laurentis Energy Partners (Opening Welcome)

The Honourable Jenna Sudds, Member of Parliament for Kanata and Parliamentary Secretary to the Minister of Government Transformation, Public Works and Procurement, and to the Secretary of State (Defence Procurement), (Opening Remarks)

James Scongack, Chair, Canadian Nuclear Isotope Council (Moderator)

Dr. Dominik Nowak, Past President, Ontario Medical Association and Department Head, Family and Community Medicine, Women's College Hospital

Dr. Rebecca Wong, Radiation Oncologist, Princess Margaret Cancer Centre and Professor, Department of Radiation Oncology, University of Toronto

Rachel Stack, Director of Business Development, Bruce Power (Closing Remarks)

Key Takeaways: